CLSD CLEARSIDE BIOMEDICAL INC Product Launches 8-K Filing 2024 - Positive Trial Results Clearside Biomedical, Inc. announced positive topline results from its Phase 2b clinical trial of CLS-AX for wet AMD on October 9, 2024, and provided a presentation and press release detailing these results.Get access to all SEC 8-K filings of the CLEARSIDE BIOMEDICAL INC